Parkinson's Disease: Coverage from San Diego

This newsletter activity highlights the latest developments in the treatment of Parkinson's disease (PD) presented at an international conference of movement disorder specialists held in San Diego, California in June 2015. 

The underlying causes of Parkinson's disease and the similarity to a number of other neurodegenerative diseases creates a great deal of confusion for patients and limits the abilities of clinicians to discuss these diseases comprehensively. Discussions at this international conference revolved around new classifications of neurodegenerative disorders by the underlying protein associated with the pathology, and with drug development models that target the protein mechanisms. A review of clinical trials specific to new agents for PD, as well as an update on Levodopa-based formulations and new delivery systems was also prominently featured.

Our Guest Editor, Robert A. Hauser, MD, attended the conference and reviewed the content of this program, providing insights into the significance of the material presented at the meeting and video commentary of the onsite presentations. 

Faculty

Robert A. Hauser, MD
Director, Parkinson's Disease and Movement Disorders Center
University of South Florida Health Byrd Institute
Tampa, Florida

 

Target Audience

Neurologists and other PD specialists, including all health care professionals who care for patients with PD, who have an interest in the most current research on the diagnosis and treatment of PD and other movement disorders. 

Learning Objectives

At the conclusion of this activity, participants should be better able to:

  • Assess evolving theories of the pathophysiology/neurobiology of PD and other movement disorders
  • Incorporate strategies for the early, accurate diagnosis of PD
  • Describe therapeutic interventions currently available to manage motor fluctuations and dyskinesias
  • Cite the data on emerging therapies for the treatment of PD

Instructions

You may participate by reading the newsletter and completing the post-activity quiz. When ready to claim your CME credit, click on and complete the "Program Evaluation" first (required) and then click on "Certificate" to receive your certificate.

This activity is supported by an educational grant from AbbVie. 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Course opens: 
08/14/2015
Course expires: 
08/13/2016
Cost:
$0.00
Rating: 
4

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.